Skip to content

Teradyne, Inc. TER Proceeds from exercises of stock options and other stock issuances

Proceeds from exercises of stock options and other stock issuances at other companies

Veeco Instruments logo
Veeco InstrumentsVECO
Onto Innovation logo
Onto InnovationONTO

Other financials

Income statement

See full
Revenue$1.3B+87.0%
Gross profit$780.9M+88.0%
Operating income$473.0M+292%
Net income$398.9M+303%
EPS (diluted)$2.53+315%

Balance sheet

See full
Cash & equivalents$241.9M-49.1%
Total debt$82.4M+19.8%
Total equity$3.1B+12.4%
Total assets$4.4B+19.6%

Cash flow

See full
Operating cash flow$265.1M+64.0%
CapEx$64.7M+1.1%
Free cash flow$200.4M+105%

Valuation

See full
Market cap$66.87B+383%
Enterprise value$66.72B+397%
P/E78.3×+54.3×
P/S17.7×+12.9×

Profitability

See full
Gross margin58.7%-0.7pp
Operating margin26.5%+4.6pp
Net margin22.6%+2.7pp
FCF margin14.6%-6.3pp

Returns & leverage

See full
Return on equity28.7%+7.2pp
Debt / equity0.0×
Current ratio2.1×-0.6×

Where this comes from

Reported directly by Teradyne, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions.

The official record: Teradyne, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances?
Teradyne, Inc. (TER) reported proceeds from exercises of stock options and other stock issuances of $15.1M in Q1 2026.
How has Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances changed year-over-year?
Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances increased by 2.1% year-over-year, from $14.79M to $15.1M.
What is the long-term trend for Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances?
Over 4 years (2021 to 2025), Teradyne, Inc.'s proceeds from exercises of stock options and other stock issuances has grown at a -0.6% compound annual growth rate (CAGR), from $32.69M to $31.86M.
What does proceeds from exercises of stock options and other stock issuances mean?
Cash inflows received by the company from employees or directors exercising stock options or purchasing shares through employee stock purchase plans. This represents the cash recovery from equity-based compensation programs.